Rodman

Rodman v. Otsuka America Pharmaceutical, Inc.

Good Law
United States District Court, Northern District of CaliforniaJuly 22, 20203:18-cv-03732California2,650 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 INA ANN RODMAN, Case No. 18-cv-03732-WHO

Plaintiff,

ORDER DENYING MOTION FOR

v. RECONSIDERATION

OTSUKA AMERICA Re: Dkt. No.

PHARMACEUTICAL, INC.,

11 Defendant.

12 Plaintiff Ina Rodman asks that I reconsider the grant of summary judgment to defendant Otsuka America Pharmaceutical, Inc. (“Otsuka”). She seeks reconsideration of the portion of my order dismissing one of her failure to warn theories based on the allegation that the label on the prescription antipsychotic medication Abilify did not accurately reflect the incidence and risk of developing a movement disorder known as Tardive Dyskinesia (“TD”). Because she either rehashes old arguments and theories raised in the summary judgment briefing or raises evidence and argument for the first time that could reasonably have been raised earlier, her motion for reconsideration is DENIED. BACKGROUND Rodman filed this product…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.